X0508 4 2023-12-13 0 0000087802 SCIENTIFIC INDUSTRIES INC SCND 0001781002 Bleichroeder LP 1345 AVENUE OF THE AMERICAS 47TH FLOOR NEW YORK NY 10105 0 0 1 0 0 Common Stock 2023-12-13 4 P 0 600000 2 A 1203351 I See footnote Warrants to Purchase Common Stock 9.5 2023-12-13 4 J 0 278947 D 2021-06-18 2026-06-18 Common Stock 278947 0 I See footnote Warrants to Purchase Common Stock 2.5 2023-12-13 4 J 0 278947 A 2023-12-13 2028-12-13 Common Stock 278947 278947 I See footnote Warrants to Purchase Common Stock 5.5 2023-12-13 4 J 0 22728 D 2022-03-02 2027-03-02 Common Stock 22728 0 I See footnote Warrants to Purchase Common Stock 2.5 2023-12-13 4 J 0 22728 A 2023-12-13 2028-12-13 Common Stock 22728 22728 I See footnote Warrants to Purchase Common Stock 2.5 2023-12-13 4 P 0 960000 A 2023-12-13 2028-12-13 Common Stock 960000 960000 I See footnote On December 13, 2023, 21 April Fund, Ltd., 21 April Fund, LP and Scientific Industries Inc. (the "Issuer") entered into an agreement (the "Securities Purchase Agreement") under which 21 April Fund, Ltd. and 21 April Fund, LP purchased from the Issuer, for an aggregate purchase price of $1,200,000, 600,000 shares of Common Stock and warrants to acquire 960,000 shares of Common Stock at an exercise price of $2.50 per share. This form is filed by Bleichroeder LP. Bleichroeder LP serves as registered investment adviser to 21 April Fund, Ltd., 21 April Fund, LP and other managed accounts. Bleichroeder LP disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that Bleichroeder LP is the beneficial owner of the securities for purposes of Section 16 or for any other purposes. On December 13, 2023, the Issuer amended the terms of (x) the 278,947 warrants with an exercise price of $9.50 per share and (y) the 22,728 warrants with an exercise price of $5.50 per share to, among other things, (i) reduce the exercise price to $2.50 and (ii) extend their exercise period to the fifth anniversary of the amendment of the warrants. Michael M. Kellen, Chairman and CO-CEO of Bleichroeder LP 2023-12-15